ribavirin has been researched along with Autoimmune Diseases in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (11.54) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (38.46) | 29.6817 |
2010's | 12 (46.15) | 24.3611 |
2020's | 1 (3.85) | 2.80 |
Authors | Studies |
---|---|
Bair, MJ; Chen, CJ; Chen, CY; Chen, JJ; Cheng, JS; Cheng, PN; Chien, RN; Chiu, YC; Chu, CH; Chuang, WL; Dai, CY; Hsu, WF; Huang, JF; Huang, YH; Hung, CH; Kao, JH; Kuo, HT; Lai, HC; Lee, PL; Lin, CW; Lin, CY; Lin, HC; Liu, CH; Liu, CJ; Lo, CC; Lo, GH; Peng, CY; Su, WW; Tai, CM; Tsai, PC; Tsai, WL; Tseng, KC; Tung, SY; Wang, CC; Wang, JH; Yan, SL; Yang, CC; Yu, ML | 1 |
Andrade, LEC; Boylan, K; Calise, SJ; Cavazzana, I; Ceribelli, A; Chan, EKL; de la Torre, IG; Fritzler, MJ; Hasegawa, T; Hiepe, F; Isailovic, N; Kohl, K; Satoh, M; Selmi, C; Shoenfeld, Y; Tincani, A; Zheng, B | 1 |
Balistreri, WF; Barton, BA; Cheng, I; Gonzalez-Peralta, RP; Haber, BA; Jonas, MM; Lobritto, SJ; Mellman, W; Mohan, P; Molleston, JP; Murray, KF; Narkewicz, MR; Njoku, D; Rosenthal, P; Schwarz, KB; Talor, MV | 1 |
Heller, T; Tana, MM | 1 |
Arama, V; Popescu, C; Popescu, GA | 1 |
D'Amico, E; D'Angelo, S; Gilio, M; Leccese, P; Olivieri, I; Palazzi, C | 1 |
Blanchard, E; Samaras, K; Vickers, CR | 1 |
Ho, HJ; Hsu, YC; Huang, YT; Lin, JT; Wang, HH; Wu, CY; Wu, MS | 1 |
Brito-Zerón, P; Cacoub, P; Casato, M; Ferri, C; Lamprecht, P; Mangia, A; Ramos-Casals, M; Retamozo, S; Saadoun, D; Tzioufas, AG; Younossi, ZM; Zignego, AL | 1 |
Hayashi, M; Kataoka, Y; Koguchi, H; Tachikawa, K; Tanaka, H | 1 |
Corcoy, R; Enríquez, J; Rigla, M; Torras, X; Vinagre, I | 1 |
Maniatis, T; Ye, J | 1 |
Battyáni, Z; Hunyady, B; Kovács, B | 1 |
Aghemo, A; Colombo, M; Degasperi, E; Ferrari, B; Lotta, LA; Peyvandi, F | 1 |
Carbone, A; Carella, C; Cioffi, M; Mazziotti, G; Morisco, F; Sorvillo, F | 1 |
Primo Vera, J | 1 |
Hsieh, CH; Tasi, TN | 1 |
Christensen, AF; Mando, OG; Ridruejo, E | 1 |
Askari, F; Conjeevaram, H; Fontana, RJ; Greenson, JK; Lok, AS; Marrero, JA; Sharma, P; Su, GL; Sullivan, P | 1 |
Evoli, A; Servidei, S | 1 |
Cacoub, P; Lunel, F | 1 |
Cervera, R; Font, J; García-Carrasco, M; Ramos-Casals, M; Trejo, O | 1 |
Codes, L; Cruz, M; Cruz, T; Ferreira, K; Paraná, R; Santos-Jesus, R | 1 |
Gerber, NL; Klassen, LW; Reinertsen, JL; Steinberg, AD; Williams, GW | 1 |
Budman, DR; Gerber, NL; Klassen, LW; Steinberg, AD; Williams, GW | 1 |
Hillyard, IW; Robins, RK; Sidwell, RW | 1 |
6 review(s) available for ribavirin and Autoimmune Diseases
Article | Year |
---|---|
An update on the management of hepatitis C virus-related arthritis.
Topics: Antirheumatic Agents; Antiviral Agents; Arthritis; Autoimmune Diseases; Cyclosporine; Disease Management; Drug Therapy, Combination; Hepacivirus; Humans; Hydroxychloroquine; Interferon-alpha; Ribavirin; Tumor Necrosis Factor-alpha | 2014 |
Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection.
Topics: Antiviral Agents; Autoimmune Diseases; Cryoglobulinemia; Evidence-Based Medicine; Hepatitis C, Chronic; Humans; Interferons; Lymphoma, B-Cell; Ribavirin; Rituximab; Vasculitis | 2017 |
[Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
Topics: Affect; Anemia, Hypochromic; Antiviral Agents; Autoimmune Diseases; Autoimmunity; Cardiovascular System; Clinical Trials as Topic; Drug Eruptions; Drug Synergism; Drug Therapy, Combination; Endocrine System Diseases; Eye; Hepatitis C, Chronic; Humans; Infections; Interferon alpha-2; Interferon-alpha; Neutropenia; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Respiratory System; Ribavirin; Risk Factors; Thrombocytopenia | 2011 |
Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
Topics: Antiviral Agents; Autoantibodies; Autoimmune Diseases; Cryoglobulinemia; Hepacivirus; Hepatitis C, Chronic; Humans; Immune Complex Diseases; Interferon-alpha; Kidney; Lichen Planus; Microsomes; Microsomes, Liver; Ribavirin; Sialadenitis; Thyroiditis, Autoimmune | 2000 |
Mixed cryoglobulinemia: new concepts.
Topics: Antiviral Agents; Autoimmune Diseases; Cryoglobulinemia; Hepatitis C; Humans; Interferon-alpha; Lupus Erythematosus, Systemic; Ribavirin; Sjogren's Syndrome | 2000 |
Ribavirin: an antiviral agent.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Autoimmune Diseases; Bacteria; Hepatitis; Humans; Immunosuppressive Agents; Plant Viruses; Ribavirin; Ribonucleosides | 1979 |
1 trial(s) available for ribavirin and Autoimmune Diseases
Article | Year |
---|---|
Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C.
Topics: Adolescent; Antiviral Agents; Autoantibodies; Autoimmune Diseases; Child; Child, Preschool; Cohort Studies; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Longitudinal Studies; Male; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; Ribavirin; United States | 2013 |
19 other study(ies) available for ribavirin and Autoimmune Diseases
Article | Year |
---|---|
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis.
Topics: Adult; Antiviral Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Lupus Erythematosus, Systemic; Male; Middle Aged; Polyethylene Glycols; Proportional Hazards Models; Ribavirin; Sustained Virologic Response; Taiwan; Viral Load | 2020 |
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies.
Topics: Aged; Antiviral Agents; Autoantibodies; Autoimmune Diseases; Female; Fluorescent Antibody Technique, Indirect; Hepatitis C; Humans; Immunoassay; Immunoprecipitation; Interferon-alpha; Laboratories; Middle Aged; Mitochondria; Reference Standards; Ribavirin | 2018 |
Autoantibodies in hepatitis C: red flag or bystander effect?
Topics: Antiviral Agents; Autoantibodies; Autoimmune Diseases; Female; Hepatitis C, Chronic; Humans; Male; Ribavirin | 2013 |
Type 1 diabetes mellitus with dual autoimmune mechanism related to pegylated interferon and ribavirin treatment for chronic HCV hepatitis.
Topics: Antiviral Agents; Autoantibodies; Autoimmune Diseases; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Hashimoto Disease; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon-alpha; Islets of Langerhans; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Vitiligo; Young Adult | 2013 |
Not so sweet: autoimmune diabetes mellitus on triple therapy for chronic hepatitis C infection.
Topics: Adult; Antiviral Agents; Autoimmune Diseases; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Oligopeptides; Polyethylene Glycols; Polymorphism, Single Nucleotide; Proline; Protease Inhibitors; Ribavirin; Young Adult | 2015 |
Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection.
Topics: Acute Coronary Syndrome; Adult; Antiviral Agents; Autoimmune Diseases; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; Stroke; Treatment Outcome | 2015 |
Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Topics: Antiviral Agents; Autoimmune Diseases; Diabetes Mellitus, Type 1; Female; Graves Disease; Hepatitis C, Chronic; Histocompatibility Antigens Class I; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
[Type 1 diabetes developing during alpha-interferon therapy: report of two cases].
Topics: Adult; Antiviral Agents; Autoantibodies; Autoimmune Diseases; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Glutamate Decarboxylase; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2010 |
Negative regulation of interferon-β gene expression during acute and persistent virus infections.
Topics: Animals; Antiviral Agents; Autoimmune Diseases; Cell Line; Cycloheximide; Fibroblasts; Gene Expression Regulation; Humans; Immunity, Innate; Inflammation; Interferon Regulatory Factor-3; Interferon-beta; Mice; Protein Synthesis Inhibitors; Respirovirus Infections; Ribavirin; Sendai virus; Signal Transduction; Viral Proteins; Virus Diseases | 2011 |
Treatment of chronic hepatitis C with pegylated interferon-α in a patient with recurrent autoimmune thrombotic thrombocytopenic purpura.
Topics: ADAM Proteins; ADAMTS13 Protein; Antiviral Agents; Autoantibodies; Autoimmune Diseases; Biopsy; Female; Hepatitis C, Chronic; Hepatomegaly; Humans; Interferon-alpha; Middle Aged; Polyethylene Glycols; Purpura, Thrombotic Thrombocytopenic; Recombinant Proteins; Recurrence; Ribavirin; Splenomegaly; von Willebrand Factor | 2013 |
Is the IFN-alpha-related thyroid autoimmunity an immunologically heterogeneous disease?
Topics: Antiviral Agents; Autoimmune Diseases; Autoimmunity; Drug Therapy, Combination; Genetic Predisposition to Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Ribavirin; Thyroid Diseases; Thyroid Gland | 2002 |
[Pegylated-interferon-induced diabetes mellitus type 1 in two patients with chronic hepatitis C].
Topics: Adult; Antiviral Agents; Autoantibodies; Autoantigens; Autoimmune Diseases; Diabetes Mellitus, Type 1; Glutamate Decarboxylase; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Islets of Langerhans; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2004 |
Development of reversible diabetes mellitus after cessation of interferon-alpha therapy for chronic hepatitis C infection.
Topics: Adult; Antiviral Agents; Autoimmune Diseases; Diabetes Mellitus; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Ribavirin | 2004 |
Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin.
Topics: Antiviral Agents; Autoimmune Diseases; Combined Modality Therapy; Female; Hepatitis C, Chronic; Humans; Hypothyroidism; Interferon alpha-2; Interferon-alpha; Magnetic Resonance Imaging; Middle Aged; Pituitary Diseases; Recombinant Proteins; Ribavirin; Thyroid Hormones | 2006 |
Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.
Topics: Adult; Antiviral Agents; Autoimmune Diseases; Female; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Ribavirin; RNA, Viral | 2007 |
Peginterferon and ribavirin for hepatitis C.
Topics: Adult; Antiviral Agents; Autoimmune Diseases; Contraindications; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Myasthenia Gravis; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |
Thyroid disease in HCV carriers undergoing antiviral therapy with interferon plus ribavirin.
Topics: Adult; Antiviral Agents; Autoimmune Diseases; Cohort Studies; Female; Hepatitis C; Hormone Replacement Therapy; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Thyroiditis | 2000 |
Ribavirin treatment in murine autoimmune disease. I. Therapeutic efficacy and effect on the immune response.
Topics: Animals; Antibodies, Antinuclear; Antibody Formation; Autoimmune Diseases; Cyclophosphamide; DNA; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Glomerulonephritis; Graft Rejection; Graft vs Host Reaction; Immune Complex Diseases; Immunity, Cellular; Injections, Intraperitoneal; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Mice, Inbred NZB; Proteinuria; Ribavirin; Ribonucleosides; RNA | 1979 |
Ribavirin: efficacy in the treatment of murine autoimmune disease.
Topics: Acetates; Animals; Antibodies, Antinuclear; Autoimmune Diseases; DNA; Levamisole; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Organophosphorus Compounds; Proteinuria; Ribavirin; Ribonucleosides; Vidarabine | 1977 |